The pooled prevalence of long COVID was 12% among unvaccinated participants and 5% among recipients of at least two vaccine doses.
Review estimates 69% 3-dose vaccine efficacy against long COVID
More from COVID-19More posts in COVID-19 »
.
The pooled prevalence of long COVID was 12% among unvaccinated participants and 5% among recipients of at least two vaccine doses.